VFA
CLBT icon

Virtus Fund Advisers’s Cellebrite CLBT Stock Holding History

Virtus Fund Advisers’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$78.2K Buy
3,551
+123
+4% +$2.37K 0.24% 33
2024
Q3 		$57.7K Hold
3,428
– – 0.24% 54
2024
Q2 		$41K Buy
3,428
+207
+6% +$2.31K 0.16% 70
2024
Q1 		$35.7K Hold
3,221
– – 0.13% 80
2023
Q4 		$27.9K Buy
+3,221
New +$25K 0.17% 90

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $18.1M AUM 29.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
CC
Crosslink Capital Menlo Park, California $1.02B AUM 9.21% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return

Virtus Fund Advisers's CLBT Position: Q4 2024 in Review

Virtus Fund Advisers increased its Cellebrite (CLBT) stake by 3.6% in Q4 2024, buying an estimated $2.37K and bringing the position to 3,551 shares worth $78.2K. The position accounts for 0.24% of the portfolio, ranked #33.

Virtus Fund Advisers first reported a position in CLBT in Q4 2023 and has held it in 5 quarters since. 191 funds tracked by Wall St. Rank hold CLBT as of Q4 2024.

  • Virtus Fund Advisers held 3,551 shares of Cellebrite worth $78.2K as of Q4 2024.
  • Virtus Fund Advisers bought 123 Cellebrite shares in Q4 2024, an estimated $2.37K.
  • Cellebrite made up 0.24% of Virtus Fund Advisers's portfolio in Q4 2024, its #33 holding.
  • Virtus Fund Advisers first reported a position in Cellebrite in Q4 2023 and has held it in 5 quarters since.
  • 191 funds tracked by Wall St. Rank held Cellebrite as of Q4 2024.

Based on Virtus Fund Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.